October 05, 2026

A new destination in abdi ibrahim’s international growth journey: north macedonia

Building on 114 years of experience and a strong vision for international growth, Abdi İbrahim has added North Macedonia to the markets where it operates. The company marked the beginning of this new chapter with a launch event in Skopje, bringing together healthcare professionals, public-sector representatives, business partners and industry stakeholders.

Building on its 24 consecutive years of leadership in the Turkish pharmaceutical industry, Abdi İbrahim continues to strengthen its position through growth in international markets, with North Macedonia becoming the latest addition to its growth journey. Today, the company operates through its own organizations in 21 countries, delivers its products to more than 70 countries and employs approximately 6,000 people across a broad geographical footprint.

A growth model shaped by local needs in every market

Abdi İbrahim continues its long-standing international growth journey through investments and partnerships across a broad geography spanning Europe, Central Asia, North Africa and the Middle East. In addition to its manufacturing operations in Türkiye, the company supports its international operations through local manufacturing investments, with facilities in Kazakhstan and Algeria offering annual production capacities of 24 million units and 51 million units, respectively. As part of its expansion in North Macedonia, the company has established its local organization and is shaping its portfolio in line with the country’s healthcare needs.

Köksal Ülgen, President of International Markets at Abdi İbrahim, commented on the significance of the company’s North Macedonia organization within its international growth journey: “Our 114 years of experience, manufacturing and R&D capabilities, expertise in biotechnology and approach to sustainability have made Abdi İbrahim a strong pharmaceutical company with a growing international presence. With our organization in North Macedonia, we are bringing this experience and expertise to a new market. We believe that understanding the healthcare needs, dynamics and priorities of each market is one of the fundamental requirements for sustainable growth. With this approach, we have established our local team in North Macedonia and are shaping our portfolio around the country’s needs. We are working closely with healthcare professionals and institutions and establishing a reliable distribution network. Our goal is to steadily grow our presence in North Macedonia through a strong local organization while supporting patients’ access to the treatment options they need.”

Abdi İbrahim to focus on five key areas in North Macedonia

Abdi İbrahim is shaping its portfolio in North Macedonia in line with local healthcare needs and its goal of supporting patient access. The company’s current focus spans five key areas: respiratory diseases, central nervous system disorders, cardiovascular diseases, pain management and over-the-counter (OTC) products.

The company’s approach for the period ahead is built around four key priorities: expanding patient access to treatment options, strengthening its local organization and collaboration with stakeholders, developing its portfolio in line with local needs, and establishing a reliable distribution network.

Abdi İbrahim also considers medical education, scientific exchange and collaborative initiatives with healthcare professionals and institutions an important part of its long-term approach in North Macedonia.

Natasha Poposka, Country Manager for North Macedonia at Abdi İbrahim, commented on the company’s local ambitions: “Our goal is to become a trusted, long-term partner to the healthcare system in North Macedonia. We are focused on understanding local needs, working closely with healthcare professionals and institutions, and supporting patient access to treatment through our scientific contribution. We believe that strong partnerships and mutual trust are fundamental to sustainable development.”